January 04, 2025 05:19 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow | Punjab cop dismissed for facilitating TV interview of Larence Bishnoi while in custody | 'Not Veer Savarkar', Congress student wing demands Delhi college be named after Manmohan Singh | 'Cowardly': PM Modi condemns New Orleans terrorist attack that killed 15 | Prashant Kishor starts fast unto death over Bihar Public Service Commission prelims cancellation demand | Bangladesh court denies bail to arrested Hindu monk Chinmoy Krishna Das
Adar Poonawalla | Covid vaccine
Image Credit: Adar Poonawalla Twitter

Vaccine hesitancy is now the greatest threat in overcoming pandemic: Adar Poonawalla

| @indiablooms | Nov 18, 2021, at 06:04 am

New Delhi/IBNS:  Serum Institute of India chief Adar Poonawalla, whose pharma company manufactured COVID-19 vaccine Covishield, on Wednesday said the hesitancy to get inoculated is the "greatest threat" in overcoming the pandemic.

Urging all those eligible to get vaccinated as soon as possible, Poonawalla said there are "over 200 million doses" of Covishield vaccine available with states.

"The vaccine industry has worked tirelessly to provide enough stocks for the nation. Today there are over 200 million doses available with states. I urge all adults to get vaccinated as soon as possible. Vaccine hesitancy is now the greatest threat in overcoming this pandemic," he said in a tweet.

AstraZeneca and Oxford University developed  Covishield and Bharat Biotech's Covaxin are the two widely used vaccines against COVID-19 in India.

India’s COVID-19 vaccination coverage has crossed 114 crore landmark milestone on Wednesday, the Centre informed in its late night bulletin.

"More than 65 lakh (65,73,687) Vaccine Doses have been administered till 7 pm today.  The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight," the statement read.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.